Literature DB >> 32494006

Molecular architecture of the human 17S U2 snRNP.

Zhenwei Zhang1, Cindy L Will2, Karl Bertram1, Olexandr Dybkov2, Klaus Hartmuth2, Dmitry E Agafonov2, Romina Hofele3,4, Henning Urlaub3,5, Berthold Kastner2, Reinhard Lührmann6, Holger Stark7.   

Abstract

The U2 small nuclear ribonucleoprotein (snRNP) has an essential role in the selection of the precursor mRNA branch-site adenosine, the nucleophile for the first step of splicing1. Stable addition of U2 during early spliceosome formation requires the DEAD-box ATPase PRP52-7. Yeast U2 small nuclear RNA (snRNA) nucleotides that form base pairs with the branch site are initially sequestered in a branchpoint-interacting stem-loop (BSL)8, but whether the human U2 snRNA folds in a similar manner is unknown. The U2 SF3B1 protein, a common mutational target in haematopoietic cancers9, contains a HEAT domain (SF3B1HEAT) with an open conformation in isolated SF3b10, but a closed conformation in spliceosomes11, which is required for stable interaction between U2 and the branch site. Here we report a 3D cryo-electron microscopy structure of the human 17S U2 snRNP at a core resolution of 4.1 Å and combine it with protein crosslinking data to determine the molecular architecture of this snRNP. Our structure reveals that SF3B1HEAT interacts with PRP5 and TAT-SF1, and maintains its open conformation in U2 snRNP, and that U2 snRNA forms a BSL that is sandwiched between PRP5, TAT-SF1 and SF3B1HEAT. Thus, substantial remodelling of the BSL and displacement of BSL-interacting proteins must occur to allow formation of the U2-branch-site helix. Our studies provide a structural explanation of why TAT-SF1 must be displaced before the stable addition of U2 to the spliceosome, and identify RNP rearrangements facilitated by PRP5 that are required for stable interaction between U2 and the branch site.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32494006     DOI: 10.1038/s41586-020-2344-3

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  52 in total

1.  Invariant U2 snRNA nucleotides form a stem loop to recognize the intron early in splicing.

Authors:  Rhonda Perriman; Manuel Ares
Journal:  Mol Cell       Date:  2010-05-14       Impact factor: 17.970

Review 2.  Spliceosome structure and function.

Authors:  Cindy L Will; Reinhard Lührmann
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

3.  The Saccharomyces cerevisiae Prp5 protein has RNA-dependent ATPase activity with specificity for U2 small nuclear RNA.

Authors:  C L O'Day; G Dalbadie-McFarland; J Abelson
Journal:  J Biol Chem       Date:  1996-12-27       Impact factor: 5.157

4.  Four yeast spliceosomal proteins (PRP5, PRP9, PRP11, and PRP21) interact to promote U2 snRNP binding to pre-mRNA.

Authors:  S W Ruby; T H Chang; J Abelson
Journal:  Genes Dev       Date:  1993-10       Impact factor: 11.361

5.  Probing interactions between the U2 small nuclear ribonucleoprotein and the DEAD-box protein, Prp5.

Authors:  Barham K Abu Abu Dayyeh; Tiffani K Quan; Marygrace Castro; Stephanie W Ruby
Journal:  J Biol Chem       Date:  2002-04-01       Impact factor: 5.157

6.  Molecular Architecture of SF3b and Structural Consequences of Its Cancer-Related Mutations.

Authors:  Constantin Cretu; Jana Schmitzová; Almudena Ponce-Salvatierra; Olexandr Dybkov; Evelina I De Laurentiis; Kundan Sharma; Cindy L Will; Henning Urlaub; Reinhard Lührmann; Vladimir Pena
Journal:  Mol Cell       Date:  2016-10-06       Impact factor: 17.970

7.  Characterization of novel SF3b and 17S U2 snRNP proteins, including a human Prp5p homologue and an SF3b DEAD-box protein.

Authors:  Cindy L Will; Henning Urlaub; Tilmann Achsel; Marc Gentzel; Matthias Wilm; Reinhard Lührmann
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

Review 8.  The spliceosome as a target of novel antitumour drugs.

Authors:  Sophie Bonnal; Luisa Vigevani; Juan Valcárcel
Journal:  Nat Rev Drug Discov       Date:  2012-11       Impact factor: 84.694

9.  Prp5 bridges U1 and U2 snRNPs and enables stable U2 snRNP association with intron RNA.

Authors:  Yong-Zhen Xu; Catherine M Newnham; Sei Kameoka; Tao Huang; Maria M Konarska; Charles C Query
Journal:  EMBO J       Date:  2004-01-08       Impact factor: 11.598

10.  ATP requirement for Prp5p function is determined by Cus2p and the structure of U2 small nuclear RNA.

Authors:  Rhonda Perriman; Imre Barta; Gia K Voeltz; John Abelson; Manuel Ares
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-10       Impact factor: 11.205

View more
  20 in total

Review 1.  Biology of the mRNA Splicing Machinery and Its Dysregulation in Cancer Providing Therapeutic Opportunities.

Authors:  Maxime Blijlevens; Jing Li; Victor W van Beusechem
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

2.  Functional and conformational impact of cancer-associated SF3B1 mutations depends on the position and the charge of amino acid substitution.

Authors:  Christine Canbezdi; Malcy Tarin; Alexandre Houy; Dorine Bellanger; Tatiana Popova; Marc-Henri Stern; Sergio Roman-Roman; Samar Alsafadi
Journal:  Comput Struct Biotechnol J       Date:  2021-02-27       Impact factor: 7.271

3.  A model for DHX15 mediated disassembly of A-complex spliceosomes.

Authors:  Hannah M Maul-Newby; Angela N Amorello; Turvi Sharma; John H Kim; Matthew S Modena; Beth E Prichard; Melissa S Jurica
Journal:  RNA       Date:  2022-01-19       Impact factor: 5.636

Review 4.  The SAGA chromatin-modifying complex: the sum of its parts is greater than the whole.

Authors:  Jelly H M Soffers; Jerry L Workman
Journal:  Genes Dev       Date:  2020-10-01       Impact factor: 11.361

Review 5.  Regulation of RNA Splicing: Aberrant Splicing Regulation and Therapeutic Targets in Cancer.

Authors:  Koji Kitamura; Keisuke Nimura
Journal:  Cells       Date:  2021-04-16       Impact factor: 6.600

6.  Rewards of divergence in sequences, 3-D structures and dynamics of yeast and human spliceosome SF3b complexes.

Authors:  Arangasamy Yazhini; Sankaran Sandhya; Narayanaswamy Srinivasan
Journal:  Curr Res Struct Biol       Date:  2021-06-15

7.  Herboxidiene Features That Mediate Conformation-Dependent SF3B1 Interactions to Inhibit Splicing.

Authors:  Adriana Gamboa Lopez; Srinivasa Rao Allu; Patricia Mendez; Guddeti Chandrashekar Reddy; Hannah M Maul-Newby; Arun K Ghosh; Melissa S Jurica
Journal:  ACS Chem Biol       Date:  2021-02-22       Impact factor: 5.100

8.  Structural basis of intron selection by U2 snRNP in the presence of covalent inhibitors.

Authors:  Constantin Cretu; Patricia Gee; Xiang Liu; Anant Agrawal; Tuong-Vi Nguyen; Arun K Ghosh; Andrew Cook; Melissa Jurica; Nicholas A Larsen; Vladimir Pena
Journal:  Nat Commun       Date:  2021-07-23       Impact factor: 14.919

9.  Nopp140-chaperoned 2'-O-methylation of small nuclear RNAs in Cajal bodies ensures splicing fidelity.

Authors:  Jonathan Bizarro; Svetlana Deryusheva; Ludivine Wacheul; Varun Gupta; Felix G M Ernst; Denis L J Lafontaine; Joseph G Gall; U Thomas Meier
Journal:  Genes Dev       Date:  2021-07-22       Impact factor: 11.361

10.  Structural insights into how Prp5 proofreads the pre-mRNA branch site.

Authors:  Zhenwei Zhang; Norbert Rigo; Olexandr Dybkov; Jean-Baptiste Fourmann; Cindy L Will; Vinay Kumar; Henning Urlaub; Holger Stark; Reinhard Lührmann
Journal:  Nature       Date:  2021-08-04       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.